Nalaganje...
Ziv-aflibercept in metastatic colorectal cancer
The combination of cytotoxic chemotherapy and antiangiogenic agents has become a conventional treatment option for patients with metastatic colorectal cancer. Ziv-aflibercept is a fusion protein which acts as a decoy receptor for vascular endothelial growth factor (VEGF)-A, VEGF-B, and placental gro...
Shranjeno v:
| Main Authors: | , |
|---|---|
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
Dove Medical Press
2013
|
| Teme: | |
| Online dostop: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3869833/ https://ncbi.nlm.nih.gov/pubmed/24368879 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/BTT.S39360 |
| Oznake: |
Označite
Brez oznak, prvi označite!
|